Immunotherapy in breast cancer: An overview of modern checkpoint blockade strategies and vaccines
Immune therapy has recently emerged as a standard-of-care strategy for the treatment of melanoma, lung cancer, bladder cancer, among other malignancies. However, the role of immune therapy in the treatment of breast cancer is still being determined. Two current strategies for harnessing the immune system to treat cancer include drugs that modulate key T cell inhibitory checkpoints and vaccines. Specifically, modern immune therapy strategies can facilitate T-cell mediated tumor regression by priming the immune system against specific tumor associated antigens, by modulating immunoregulatory signals, or both.
Source: Current Problems in Cancer - Category: Cancer & Oncology Authors: Katherine Sanchez, David Page, Heather L. McArthur Tags: Massarweh: Breast Cancer Source Type: research
More News: Bladder Cancer | Breast Cancer | Cancer | Cancer & Oncology | Cancer Vaccines | Immunotherapy | Lung Cancer | Melanoma | Skin Cancer | Vaccines